Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Tuesday 27 November, 2018

Benchmark Hlgs PLC

Successful defence of patent infringement in Asia

RNS Number : 5471I
Benchmark Holdings PLC
27 November 2018


27 November 2018



Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")


Successful defence of patent infringement in Asia


Benchmark Holdings, the aquaculture genetics, health and nutrition business, announces that it has successfully prosecuted infringement of its patents by Marine-Tech International ("MTI") in Thailand (Thai Patent No. 38834 and Thai Patent No. 47896). The IP&IT court in Bangkok, Thailand has ruled that MTI infringed both patents, has ordered MTI to cease using Benchmark's patented technology and has awarded damages in Benchmark's favour, which may yet be subject to appeal.


These patents relate to the Company's market leading Artemia hatching and enrichment technologies, an important element of its advanced nutrition solutions. Following a period of dialogue with MTI, during which the Company requested MTI to cease and desist from using its patented technology, the Group filed a complaint at the IP&IT court in Bangkok in 2017. The summary judgement in favour of Benchmark was announced on 22nd November 2018.


The Company actively protects intellectual property rights, and this success demonstrates the robustness of Benchmark's patents and its ability to defend them globally in key markets.


Benchmark has a strong patent portfolio across products and processes in all of its three main divisions, which is the result of its advanced innovation, research and development and associated investment over the years. The Company's portfolio with 37 families and 221 patents is well balanced, with a mixture of robust granted applications to protect current products and new patent applications to support the business in the future.


Commenting on the Court ruling, Malcolm Pye, CEO, said:


"We are pleased the IP&IT court in Bangkok has ruled in our favour, vindicating the intellectual property which underpins the value of our innovative solutions and future product pipeline. Robust intellectual property protection will continue to be a core strategic area of focus for the Group."


Athene Blakeman, Group Legal Counsel, said:


"Benchmark robustly protects its intellectual property assets across the world and proactively monitors the market and our competitors for infringement. This intellectual property has been developed through many years of investment in cutting edge R&D and, while Benchmark strongly supports open and fair competition, we will take all necessary action, including initiating legal procedures as in this case, where we identify unfair infringement of our intellectual property."



For further information, please contact:


Benchmark Holdings plc

Tel: 020 7260 1000

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications


Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)


Katie Hunt / Reg Hoare /Alistair de Kare-Silver     

Tel: 020 3128 8742                                 
07551 170 451

[email protected]


Notes to Editors:


Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services to serve its customers, helping them improve yield and efficiency in a sustainable way.


The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries and as at 31 March 2018 employed 1,028 people.


For further information on Benchmark please visit


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t